Announced
Completed
Financials
Tags
Private
Single Bidder
Acquisition
Venture Capital
Medical Equipment
Minority
Friendly
Singapore
Completed
Private Equity
Cross Border
invitro diagnostic systems
Synopsis
Sequoia Capital China, a VC firm focused on seed stage, mid stage, late stage, and growth investments in the fintech sector, and Morningside Ventures, a private equity firm, led a $100m Series B financing round in Virtue Diagnostics, an in-vitro diagnostics company. "Virtue's strategy is to introduce new technology platforms by cooperating with global technology companies, developing products and solutions specifically geared for the Chinese market and accelerating the time to market through our highly experienced team of R&D, registration and commercial professionals," Johnson Zhang, Virtue Diagnostics CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.